Operationalizes an AI-enabled genomic medicine platform that unifies epigenomic profiling with precise target engineering to develop adipose-targeted RNA therapeutics for cardiometabolic diseases.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Moonwalk Biosciences provisions a commercial-stage genomic medicine, AI-driven target discovery, and precision epigenetic engineering platform engineered to reprogram cellular states and unlock novel therapeutics for metabolic diseases and obesity. The biotechnology technology ecosystem unifies multi-omic single-cell epigenomic profiling, proprietary target-prediction engines, tissue-specific siRNA design frameworks, and extrahepatic delivery vectors into a centralized therapeutic discovery control plane.
Moonwalk Biosciences Funding
Sign up to gain insights into Moonwalk Biosciences funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series B | Sep 08, 2026 | 70M | ||
| Series A-1 | Jan 04, 2024 | 7M | ||
| Series A | Jan 04, 2024 | 50M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Moonwalk Biosciences Management Team
Investors
Alpha Wave Ventures
ARCH Venture Partners
Eli Lilly & Company
Future Ventures
Google Ventures
Khosla Ventures
YK Bioventures
Moonwalk Biosciences Valuations & Financials
View real-time NPM data on Moonwalk Biosciences stock including daily Moonwalk Biosciences stock price estimates, valuation history, and historical share price information. Access Moonwalk Biosciences financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Moonwalk Biosciences pricing across six independent market signals. Looking for private company due diligence data sources on Moonwalk Biosciences? Get in touch to learn more.
Similar Companies
like Moonwalk Biosciences
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Cygnvs
Cybersecurity
Provides cybersecurity platform for coordinating incident response across teams, enabling efficient crisis management and compliance reporting.
Silverfin
Cloud-based platform streamlines financial reporting and compliance workflows for accounting firms through automated tools and collaborative features.
Regard
Healthcare & Life Sciences
AI platform integrates with electronic health records to assist physicians with diagnosis suggestions and automated clinical documentation.
Rapido
Connects riders with vehicle drivers for affordable, on‑demand transport and delivery services via an app.
SEI
AI & Machine Learning
AI platform that automates compliance and customer experience operations for financial institutions through intelligent task automation.
Exos Financial
Delivers data-driven investment banking infrastructure and quantitative asset management solutions to optimize institutional capital workflows.
Cantarell
Climate & Sustainability
Energy solutions provider specializing in hydrocarbon development, distribution, and industrial services with focus on sustainability and efficiency.
Lumos
Empowers employees with self-service app access while streamlining compliance, access reviews, and license management for enterprises.
FAQ
We have answers
Moonwalk Biosciences stock does not trade on public stock exchanges. Moonwalk Biosciences stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Moonwalk Biosciences stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Moonwalk Biosciences Stock does not trade on public stock exchanges. In order to sell Moonwalk Biosciences shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Moonwalk Biosciences does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Moonwalk Biosciences share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Moonwalk Biosciences stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Moonwalk Biosciences stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Moonwalk Biosciences stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Moonwalk Biosciences is a private company and has not had an IPO. There is currently no Moonwalk Biosciences IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Moonwalk Biosciences IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
